Kurzporträt
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Gene Therapeutics
100,0
%
| 0 | nan % | 4 | 100,0 % | - |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 4 | 100,0 % | - |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Laurent Fischer
CEO | Chief Executive Officer | 60 | 15.06.20 |
Linda Rubinstein
DFI | Director of Finance/CFO | 58 | 12.12.22 |
Bill Tan
CTO | Chief Tech/Sci/R&D Officer | - | 01.03.21 |
Romuald Corbau
CTO | Chief Tech/Sci/R&D Officer | 55 | 29.01. |
Peter Soparkar
COO | Chief Operating Officer | 53 | 30.10.19 |
R. Ramelmeier
CTO | Chief Tech/Sci/R&D Officer | 62 | 21.08.23 |
Rabia Ozden
CTO | Chief Tech/Sci/R&D Officer | 56 | 17.03.22 |
Anand Reddi
HRO | Human Resources Officer | 42 | - |
Star Seyedkazemi
PRN | Corporate Officer/Principal | 50 | 06.01.22 |
Corporate Officer/Principal | - | 25.06.20 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Scott Whitcup
BRD | Director/Board Member | 64 | 16.04.20 |
Clarence Machado
CHM | Chairman | 60 | 14.03.17 |
Laurent Fischer
CEO | Chief Executive Officer | 60 | 15.06.20 |
Jim Scopa
BRD | Director/Board Member | 65 | 01.05.19 |
C. Nicholson
BRD | Director/Board Member | 69 | 03.11. |
Mark Lupher
BRD | Director/Board Member | 53 | 01.05.19 |
Reed Tuckson
BRD | Director/Board Member | 73 | 19.02.21 |
Dawn Svoronos
BRD | Director/Board Member | 70 | 09.12.20 |
Rabia Ozden
CTO | Chief Tech/Sci/R&D Officer | 56 | 17.03.22 |
Soo Hong
BRD | Director/Board Member | 52 | 17.03.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 20 756 850 | 20 386 246 ( 98,21 %) | 0 | 98,21 % |
Unternehmenskontakt
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+16,79 % | 122 Mrd. | |
+19,99 % | 115 Mrd. | |
+21,22 % | 26,64 Mrd. | |
-23,17 % | 19,91 Mrd. | |
-17,47 % | 16,32 Mrd. | |
-45,95 % | 15,52 Mrd. | |
-18,64 % | 15,49 Mrd. | |
+60,82 % | 14,83 Mrd. | |
+3,35 % | 13,67 Mrd. |